Screening compound: NMIOUYXBTZBRFU-UHFFFAOYSA-N

Screening compound: NMIOUYXBTZBRFU-UHFFFAOYSA-N
Screening compound: NMIOUYXBTZBRFU-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
NMIOUYXBTZBRFU-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

8001-3950

Molecular Formula

C28H32N2O2 (C28 H32 N2 O2)

Compound Name

N1,N3-bis({[4-(propan-2-yl)phenyl]methyl})benzene-1,3-dicarboxamide

IUPAC name

N1N3-bis({[4-(propan-2-yl)phenyl]methyl})benzene-13-dicarboxamide

SMILES

CC(C)c1ccc(CNC(c2cccc(C(NCc3ccc(C(C)C)cc3)=O)c2)=O)cc1

InChI

InChI=1S/C28H32N2O2/c1-19(2)23-12-8-21(9-13-23)17-29-27(31)25-6-5-7-26(16-25)28(32)30-18-22-10-14-24(15-11-22)20(3)4/h5-16,19-20H,17-18H2,1-4H3,(H,29,31)(H,30,32)

InChI Key

NMIOUYXBTZBRFU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00331942

NMIOUYXBTZBRFU-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

Anti-infective Library (19449 compounds)

CORONAVIRUS Library (20774 compounds)

Glucocorticoid receptors Library (4806 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Nuclear receptors
  • Others
  • Proteases
  • Phosphatases
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with NMIOUYXBTZBRFU-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound NMIOUYXBTZBRFU-UHFFFAOYSA-N?
Check Price and Availability of NMIOUYXBTZBRFU-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of NMIOUYXBTZBRFU-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for NMIOUYXBTZBRFU-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for NMIOUYXBTZBRFU-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of NMIOUYXBTZBRFU-UHFFFAOYSA-N available by request